08/13/2020
Neurology Consultant Advisory Board Member Pavan Bhargava, MD, discusses how he and his colleagues are treating patients with multiple sclerosis via telemedicine amid the ongoing pandemic.
Additional Resources:
- National Multiple Sclerosis Society. Disease modifying treatment guidelines for coronavirus (COVID-19). https://www.nationalmssociety.org/What-you-need-to-know-about-Coronavirus-(COVID-19)/DMT-Guidelines-for-Coronavirus-(COVID-19)-and Accessed on April 6, 2020.
- International Multiple Sclerosis Foundation. The coronavirus and MS – global advice. https://www.msif.org/news/2020/02/10/the-coronavirus-and-ms-what-you-need-to-know/ Last updated on March 31, 2020. Accessed on April 6, 2020.
Pavan Bhargava, MD, MBBS, is an assistant professor of neurology in the Division of Neuroimmunology and Neurological Infections at the Johns Hopkins School of Medicine in Baltimore, Maryland.